Title

Food and Drug Committee FDA Flash! - Update in Amgen v. Sandoz Filgrastim and Pegfilgrastim Litigation

Announcement Description

Check out our new FDA Flash! article, Update in Amgen v. Sandoz Filgrastim and Pegfilgrastim Litigation​:  Federal Circuit Finds State Law Claims Preempted and District Court Dismisses Amgen's Infringement Claims, by Laura W. Smalley, Member, Harris Beach PLLC (December 28, 2017).

Expires

 

Attachments

Created at 1/5/2018 11:22 AM by Shana Cyr
Last modified at 1/5/2018 11:22 AM by Shana Cyr